M. Licour

发表

Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry

S. Pocock, F. Van de Werf, H. Bueno, 2016, Open Heart.

Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elev

W. Cantor, S. Goodman, G. Montalescot, 2013, American heart journal.

Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns

S. Pocock, F. Van de Werf, J. Jukema, 2016, European heart journal. Acute cardiovascular care.

Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.

J. Tardif, M. Santini, B. Merkely, 2010, Archives of cardiovascular diseases.

Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

W. Cantor, B. Merkely, K. Huber, 2018, American Journal of Cardiovascular Drugs.

Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.

E. Vicaut, J. Tardif, M. Santini, 2008, Archives of cardiovascular diseases.

Prehospital ticagrelor in ST-segment elevation myocardial infarction.

E. Vicaut, W. Cantor, B. Merkely, 2014, The New England journal of medicine.

Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study.

N. Normanno, O. Molinier, M. Denis, 2019, Journal of thoracic disease.

Werf, F; (2014) Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome

S. Pocock, H. Bueno, F. Werf, 2019 .

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study

S. Pocock, F. Van de Werf, H. Bueno, 2015, European heart journal. Acute cardiovascular care.

Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS.

S. Pocock, F. Van de Werf, H. Bueno, 2017, Revista espanola de cardiologia.

How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.

A. Garnham, R. Garzonio, T. Visakorpi, 2022, Clinical genitourinary cancer.

Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.

E. Vicaut, W. Cantor, B. Merkely, 2015, JACC. Cardiovascular interventions.

Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study

S. Pocock, F. Van de Werf, F. Werf, 2015, European heart journal. Acute cardiovascular care.

Abstract 15409: Differences in 1-Year Mortality Risk Between Survivors of ST-Segment Elevation and Non ST-Segment Elevation ACS: Insights From the EPICOR Study

S. Pocock, H. Bueno, F. Werf, 2013 .

Vandetanib In Locally Advanced Or Metastatic Differentiated Thyroid Cancer (Papillary Or Follicular; Dtc): A Randomized, Double-Blind Phase Ii Trial

L. Bastholt, M. Schlumberger, A. Awada, 2010 .

Treatment Characteristics and Real-World Progression-Free Survival in Patients with Unresectable Stage III NSCLC who Received Durvalumab After Chemoradiotherapy: Findings from the PACIFIC-R Study.

N. Girard, R. Fietkau, B. Markman, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.

Thomas Krause, Christine Soufflet, Françoise Bonichon, 2012, The Lancet. Oncology.

TCT-215 Predictors of 1-year mortality at hospital discharge after ACS STEMI and NSTE-ACS: a new risk score from the EPICOR study

S. Pocock, H. Bueno, F. Werf, 2013 .

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy.

N. Girard, S. Peters, R. Fietkau, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

1171MO PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Peters, R. Fietkau, 2021, Annals of Oncology.

2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU)

I. Ray-Coquard, A. Floquet, P. Follana, 2015 .

79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

N. Girard, S. Siva, A. Allen, 2021 .

Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry

S. Pocock, F. Van de Werf, H. Bueno, 2016, Open Heart.

IMPACT OF MORPHINE ADMINISTRATION ON TICAGRELOR-INDUCED PLATELET INHIBITION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED BY PRIMARY PCI: RESULTS FROM THE PRIVATE-ATLANTIC STUDY

E. Vicaut, G. Montalescot, J. Collet, 2015 .

Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS.

S. Pocock, F. Van de Werf, H. Bueno, 2017, Revista espanola de cardiologia.